Showing results (151-160 of 335) with videos related to
Sort By:
Pageof 34
Clinical Transplants|September 6, 2002
Early and long-term results using older kidneys from cadaver or living donorsL Berardinelli, C Beretta, M Raiteri, et al.Journal of Neuroscience Research|August 24, 2000
Study of the bidirectional transport of choline by blocking choline carriers from outside or inside brain nerve terminalsM Marchi, F Bergaglia, A Pedrini, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|May 27, 1999
Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slicesA Pittaluga, A Bonfanti, D Arvigo, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1983
Differential blockade by (-)mianserin of the alpha 2-adrenoceptors mediating inhibition of noradrenaline and serotonin release from rat brain synaptosomesM Raiteri, G Maura, A Gemignani, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1990
Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterizationM Raiteri, M Marchi, P Paudice, et al.European Journal of Pharmacology|July 15, 1983
Is acetylcholine release from striatal nerve endings regulated by muscarinic autoreceptors?M Marchi, P Paudice, A Caviglia, et al.Journal of Neuroscience Research|January 1, 1987
Is the muscarinic receptor that mediates potentiation of dopamine release negatively coupled to the cyclic GMP system?M Marchi, P Paudice, A Gemignani, et al.Neuroscience Letters|January 16, 1989
Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomesM Marchi, P Bocchieri, L Garbarino, et al.Brain Research|February 13, 1976
Decrease of uptake and exchange of neurotransmitter amino acids after depletion of their synaptosomal poolsG Levi, A Coletti, U Poce, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|June 13, 2009
Targeting indoleamine 2,3-dioxygenase (IDO) to counteract tumour-induced immune dysfunction: from biochemistry to clinical developmentS Rutella, G Bonanno, R De CristofaroPageof 34